Lameness poses a considerable problem in modern dairy farming. Several new developments (e.g., herd health plans) strive to help farmers improve the health and welfare of their herd. It was thus our aim to identify lameness risk factors common across regions, breeds, and farming systems for freestall-housed dairy cows. We analyzed data from 103 nonorganic and organic dairy farms in Germany and Austria that kept 24 to 145 Holstein Friesian or Fleckvieh cows in the milking herd (mean = 48). Data on housing, management, behavior, and lameness scores for a total of 3,514 cows were collected through direct observations and an interview. Mean lameness prevalence was 34% (range = 0-81%). Data were analyzed applying logistic regression with generalized estimating equations in a split-sample design. The final model contained 1 animal-based parameter and 3 risk factors related to lying as well as 1 nutritional animal-based parameter, while correcting for the significant confounders parity and data subset. Risk for lameness increased with decreasing lying comfort, that is, more frequent abnormal lying behavior, mats or mattresses used as a stall base compared with deep-bedded stall bases, the presence of head lunge impediments, or neck rail-curb diagonals that were too short. Cows in the lowest body condition quartile (1.25-2.50 for Holstein Friesian and 2.50-3.50 for Fleckvieh) had the highest risk of being lame. In cross-validation the model correctly classified 71 and 70% of observations in the model-building and validation samples, respectively. Only 2 out of 15 significant odds ratios (including contrasts) changed direction. They pertained to the 2 variables with the highest P-values in the model. In conclusion, lying comfort and nutrition are key risk areas for lameness in freestall-housed dairy cows. Abnormal lying behavior in particular proved to be a good predictor of lameness risk and should thus be included in on-farm protocols. The study is part of the European Commission's Welfare Quality project.

The series of quinaldine derivatives were prepared, some of them by means of novel synthetic methods. The synthetic approach, analytical and spectroscopic data of all newly synthesized compounds are presented. The prepared compounds were tested for their in vitro antifungal activity as well as for their photosynthesis-inhibiting activity (the inhibition of photosynthetic electron transport in spinach chloroplasts (Spinacia oleracea L.) and the reduction of chlorophyll content in Chlorella vulgaris Beij.). Structure-activity relationships among the chemical structure, the physical properties and the biological activities of the evaluated compounds are discussed in the article.

Organophosphate pesticides (OPPs; e.g. chlorpyrifos, diazinon, paraoxon) are a wide and heterogeneous group of organophosphorus compounds. Their biological activity of inhibiting acetylcholinesterase (AChE) or butyrylcholinesterase (BChE) ranks them as life endangering agents. The necessary treatment after OPP exposure involves the use of parasympatolytics (e.g. atropine), oxime reactivators (e.g. obidoxime), and anticonvulsive drugs (e.g. diazepam). Therefore, the reactivators of AChE are essential compounds in the treatment of OPP intoxications. Commercial AChE reactivators (e.g. pralidoxime, HI-6, obidoxime, trimedoxime, methoxime) were originally developed for other members of the organophosphate family, such as nerve agents (e.g. sarin, soman, tabun, VX). Pralidoxime, HI-6, and methoxime were found to be weak reactivators of OPP-inhibited AChE. Obidoxime and trimedoxime showed satisfactory reactivation against various OPPs with minor toxicity issues. During the last two decades, the treatment of OPP exposure has become more widely discussed because of growing agricultural production, industrialization, and harmful social issues (e.g. suicides). In this review is the summarized design, evaluation, and structure-activity relationship studies of recently produced AChE reactivators. Since pralidoxime, over 300 oximes have been produced or tested against OPP poisoning, and several novel compounds show very promising abilities as comparable (or higher) to commercial oximes. Some of these are highlighted for their further testing of OPP exposure and, additionally, the main structure-activity relationship of AChE reactivators against OPP is discussed.

No abstract

Nine potential AChE reactivators were synthesized using a modification of currently known synthetic pathways. Their potency to reactivate AChE inhibited by insecticide chlorpyrifos was tested in vitro. 2,2'-Bis(hydroxyiminomethyl)-1,1'-(1,4-phenylenedimethyl)-bispyridinium dibromide seems to be the most potent AChE reactivator. The reactivation potency of these compounds depends on structural factors such as length of the linking chain between both pyridinium rings and position of the oxime moiety on the pyridinium ring.